of 5 635 base-pairs in certain DQB1 alleles. Regarding LTR5, it showed identical distribution to LTR3, consistently with a previously suggested LTR3-LTR5 tandem arrangement.
In their study, Bieda et al. mention their previous reports suggesting that LTR3 might have an additive effect in the contribution of the HLA class II region to predisposition to rheumatoid arthritis (RA) and IDDM [6, 7] . With our work we showed that the undetected deletion in the flanking region of some DQB1 alleles and a lack of stratification for HLA typing explains previously reported associations of the LTR3 element with RA and Type 1 diabetes (IDDM).
Unfortunately, Bieda et al. do not mention our findings on the distribution of LTR elements in HLA-DQB1 alleles. The comment they make on our article is reduced to page 444 line 12 "a significant association for DQB1*0601-LTR13 + with RA has been reported". In our article we clearly state that positivity for LTR elements did not increase the risk of developing RA by itself. The only exception would be the LTR3-positive DQB1*0601 allele (seven cases against one control). However, the numbers are too small to be interpretable and would require confirmation in other patients' and controls' data. Moreover, a role of LTR3 in RA susceptibility would be inconsistent with the fact that both DQB1*0302-DR4 and DQB1*0301-DR4 haplotypes are associated with RA, the former being LTR3-and LTR5-positive while the DQB1 5′-flanking region of the latter only contains a deletion.
We would like to emphasize that careful analysis of polymorphisms can allow the identification of stable HLA configurations, thereby avoiding potential confounder effects of an adjacent locus when reporting associations of particular markers with disease predisposition. Likewise, a thorough knowledge of allele distributions among loci could lead to a simplified typing of HLA haplotypes rather than particular loci. Such information would not only be valuable for phylogeny, population and disease association studies but even more when looking for HLA matching prior to transplantation. To the Editor: We read with interest the recent article by Bieda et al. [1] , which indicates that the retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) marks additional genetic risk for Type 1 diabetes (IDDM) on high risk DQ haplotypes.
We recently reported the detailed polymorphism of the 5′-flanking region of the HLA-DQB1 alleles [2] . In this study, we analysed the presence of LTR13 (along with the presence of LTR3 and LTR5, also located in the close vicinity of DQB1) in a case-control study and a large panel of homozygous B-cell lines. Interestingly, we found that every single LTR typing could be explained by linkage disequilibrium with DQB1 alleles, independently of the haplotypes carrying them. Regarding LTR13, positivity was always associated with DQB1*0302, *0303 and *0402 alleles. Although family studies should be carried out to validate the linkages, 345 individuals and 42 B-cell lines followed entirely the LTR pattern established and therefore we believe that LTR13 has no additive value over HLA-DQB1 in predisposition to autoimmune diseases.
Given the complete linkage disequilibrium between LTR13 and DQB1*0302, *0303 and *0402 alleles, the conclusion of Bieda et al. that LTR13, within the HLA region, is an "additional and independent" genetic risk marker in IDDM, is not correct. Nevertheless, given the fact that the associations of DQB1*0302, DQB1*0303 and DQB1*0402 with IDDM are well-established and that only these three alleles are LTR13-positive, and considering that LTR elements are known to regulate gene expression, an interesting hypothesis would have been the analysis of the possible involvement of LTR13 in the association of DQB1*0302, *0303 and *0402 with IDDM.
The human genome contains between 30 and 50 proviral copies of human endogenous retroviruses (HERV) and up to 25 000 copies of their solitary long terminal repeats (LTRs). Insertions and deletions of these retroviral sequences have probably played an important role in generating the HLA diversity [3] . Of these, three HERV-LTR sequences, i.e. LTR13 along with LTR3 and LTR5, are inserted in the vicinity of the DQB1 locus as mentioned above [4, 5] . In our study [2] , LTR3 positivity was always associated with certain DQB1 alleles and sequencing analysis of the 5′-flanking region in homozygous B cell lines showed the absence of LTR3 and a massive deletion
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with selected DQA1/DQB1 haplotypes and the calculation of the relative risk (RR) clearly indicated that the risk mediated by the DQ-LTR13 is additional to those conferred by DQ2 and DQ8, respectively. The term "independent" referred to the linkage disequilibrium (LD) between the previously reported DQ-LTR3 [4] and DQ-LTR13. This LD was so distinct that both could be considered as independent genetic risk markers.
We differentiated between the transmission of DQ8/LTR13 + vs. DQ8/LTR13 − and DQ2/LTR13 + vs. DQ2/LTR13 − haplotypes in a transmission distortion test and obtained a significant preferential transmission of DQ8/LTR13 + compared with DQ8/LTR13 − . DQ2 in contrast was significantly more often transmitted without DQ-LTR13 [1] . This transmission pattern obviously depends on these two haplotypes as we could show a distinct pattern for all not-DQ2/not-DQ8 haplotypes that differs for the presence of DQ-LTR13.
Pascual et al. find DQ-LTR13 positivity "always" associated with DQB1*0302, *0303 and 0402 alleles. This is in contrast to our results of some DQB1*0302/LTR13-negative as well as DQB1*0201/LTR13-positive alleles. The allele DQB1*0302 is more often associated with presence of DQ-LTR13 than with its absence, but DQ-LTR13 is not confined to the three DQB1 alleles mentioned above, but also found in DQB1*0201(5%), DQB1* 0301(7%), DQB1*0501(7%), DQB1*0502(8%), DQB1*0602(4%) and DQB1*0603(5%) [6] . The discrepancy of the two reports is therefore most probably due to the smaller sample of haplotypes studied in the Spanish data set.
The main interest of our study was to characterize DQ-LTR13 as a possible genetic risk marker to IDDM. Previous reports suggesting that "DQ-LTR3 might have an additive effect in the contribution of HLA class II alleles to predisposition to rheumatoid arthritis (RA) and IDDM" [5, 6] represent an earlier state of knowledge and have to be seen in the light of our current data. As clearly pointed out in our publication, the effect of DQ-LTR13 is independent from DQ-LTR3. The massive deletion in the 5'-flanking region of the DQB1 gene and its association with the absence of DQ-LTR3 in certain DQB1 alleles described by Pascual et al. has therefore no influence on the results obtained for DQ-LTR13 as it is located outside this deletion.
Due to the complexity of the two diseases and the different populations studied the two reports do not necessarily contraLetters
To the Editor: Although we refer to Pascual's study in our original paper [1] , these authors like to reiterate their earlier conclusion that DQ-LTR13 is not associated with "autoimmunity" [2] . However the two studies are completely different and therefore not comparable.
Pascual et al. [3] analysed 145 patients with rheumatoid arthritis (RA), 200 healthy controls and 42 selected homozygous cell lines. In contrast we investigated 284 complete families comprising of both parents and at least one child affected by Type 1 diabetes (IDDM) which enabled us to analyse the segregation of 1136 haplotypes with DQ-LTR13, DQA1 and DQB1 alleles and their transmission to patients [1] . Thus our data quality is completely different in comparison to Pascual's study of unrelated individuals which does not allow the assignment of linkage between DQ-LTR13 and DQ in heterozygous individuals. Furthermore we addressed IDDM in Germany and Belgium, whereas Pascual et al studied RA in Spain. Although Pascual et al announce the importance of family studies in their original contribution, they have not obtained any additional data so far. We can therefore only encourage them to carry out transmission distortion tests (TDT) in trio families because only the complete assignment of parental co-transmission or non-transmission can answer the question of an independent DQ-LTR13 association with a complex disease such as RA.
We confirm our results leading to the conclusion that DQ-LTR13 is an "additional and independent genetic risk marker" in IDDM. The combined transmission of DQ-LTR13
